UTMB Pepper Center Lecture Highlights Advances in Targeting Skeletal Muscle for Healthy Aging

A recent lecture at the UTMB Pepper Center by Shalender Bhasin, MB, BS, Harvard Medical School, spotlighted emerging strategies to improve health and longevity in older adults by targeting skeletal muscle. A video of this lecture in now available: Click to view Targeting Skeletal Muscle to Improve the Health and Wellbeing of Older Adults online.

Key Takeaways

Skeletal muscle decline is central to aging-related health risks
Dr. Shalender Bhasin emphasized that aging leads to progressive loss of muscle mass, strength, and function. This decline contributes to increased frailty, falls, fractures, metabolic disorders, and ultimately reduced health span and lifespan.

Muscle-focused interventions show broad health benefits
Early studies suggest that improving muscle health can have wide-ranging effects beyond mobility, including:

• Lower blood pressure in hypertensive individuals
• Reduced cholesterol levels
• Improved walking capacity in peripheral artery disease
• Reduced inflammation in neurological conditions (e.g., Parkinson’s disease)
• Enhanced aerobic capacity and physical function

Clinical trials are underway to explore benefits in Alzheimer’s disease, diabetes, kidney disease, and cardiac conditions.

Caution: early trial results may overestimate impact
While promising, the speaker noted that many current studies are small and short-term. These trials often highlight positive outcomes and may not fully capture long-term safety or true effectiveness.

Need for large-scale, rigorous clinical trials
The field faces a critical gap: a lack of large, well-powered trials capable of producing evidence strong enough for regulatory approval. Current research is fragmented, making it difficult to define standardized endpoints and outcomes for “healthspan extension.”

Global urgency for scalable aging interventions
With rapidly aging populations worldwide—especially in countries undergoing fast demographic shifts—there is growing demand for interventions that can extend not just lifespan, but healthy years of life.

Call for collaboration and “big science” approach
The speaker called for a coordinated effort across academia, industry, and regulatory agencies—likening the need to “Manhattan Project”-scale collaboration—to advance therapies targeting muscle and aging.

Promising therapeutic pipeline
Several drugs aimed at improving muscle mass, strength, and function have already shown success in Phase 2 trials. Combining these therapies with exercise interventions and validated outcome measures could pave the way for larger, definitive studies.

Looking Ahead

The lecture concluded on an optimistic note: targeting skeletal muscle represents a viable and impactful pathway to extend health span. With stronger collaboration and larger clinical trials, the field is positioned to translate promising science into real-world aging interventions.